Evotec SE (EVO) Gross Margin (2009 - 2025)
Evotec SE (EVO) posted Gross Margin of 30.99% for Q4 2025, up 100.08% sequentially from 37830.94% in Q3 2025, and up 1015.0% YoY from 2.78% in Q4 2024.
Evotec SE (EVO) Gross Margin (2009 - 2025) Analysis & Trends
Evotec SE has reported Gross Margin for 9 years, with the latest figure at 30.99% in Q4 2025.
- Quarterly Gross Margin rose 1015.0% year-over-year to 30.99% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 7811.12% (down 783135.0% YoY) and the FY2025 annual result came in at 14485032.98%, up 1448501856.0% from the prior year.
- Gross Margin rose to 30.99% in Q4 2025 per EVO's latest filing, from 37830.94% in the prior quarter.
- Over five years, Gross Margin peaked at 30.99% in Q4 2025 and troughed at 37830.94% in Q3 2025.
- A 5-year average of 2502.52% and a median of 19.61% in 2022 frame the typical range for Gross Margin.
- The widest YoY moves for Gross Margin: up 1015 bps in 2025, down 3784083 bps in 2025.
- Over 5 years, Gross Margin stood at 23.08% in 2021, then fell by 22 bps to 17.94% in 2022, then soared by 32 bps to 23.68% in 2023, then slipped by 12 bps to 20.84% in 2024, then soared by 49 bps to 30.99% in 2025.
- According to Business Quant data, Gross Margin over the past three periods registered 30.99%, 37830.94%, and 20.84% for Q4 2025, Q3 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 51.98% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 42.63% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 66.66% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 87.30% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 38.77% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 97.58% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 58.33% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Evotec SE | 687.23 Mn | 686.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.99% |
| Sep 30, 2025 | -37,830.94% |
| Dec 31, 2024 | 20.84% |
| Sep 30, 2024 | 9.89% |
| Dec 31, 2023 | 23.68% |
| Sep 30, 2023 | 19.27% |
| Jun 30, 2023 | 24.93% |
| Dec 31, 2022 | 17.94% |
| Sep 30, 2022 | 16.34% |
| Jun 30, 2022 | 17.94% |
| Mar 31, 2022 | 19.61% |
| Dec 31, 2021 | 23.08% |
| Sep 30, 2021 | 27.04% |
| Jun 30, 2021 | 18.54% |
| Mar 31, 2021 | 23.05% |
| Dec 31, 2020 | 24.75% |
| Dec 31, 2019 | 29.77% |
| Sep 30, 2010 | 42.01% |
| Jun 30, 2010 | 49.75% |
| Mar 31, 2010 | 37.89% |